EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
about
Restoration of the anti-proliferative and anti-migratory effects of 1,25-dihydroxyvitamin D by silibinin in vitamin D-resistant colon cancer cells.Suppression of epithelial ovarian cancer invasion into the omentum by 1α,25-dihydroxyvitamin D3 and its receptorCellular and molecular effects of vitamin D on carcinogenesis.Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.Extraskeletal actions of vitamin D.Potent 19-norvitamin D analogs for prostate and liver cancer therapySkeletal metastasis: treatments, mouse models, and the Wnt signaling.The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer.Vitamin D and cancer: the promise not yet fulfilled.The future of vitamin D analogs.Current progress in using vitamin D and its analogs for cancer prevention and treatment.Vitamin D in cancer chemoprevention.Novel vitamin d analogs for prostate cancer therapyParathyroid hormone-related protein regulates integrin α6 and β4 levels via transcriptional and post-translational pathways1,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways.Vitamin D analog EB1089 could repair the defective bone marrow-derived mesenchymal stromal cells in patients with systemic lupus erythematosus.
P2860
Q35568534-CA39978E-86D7-4C09-BBF6-986195592B2CQ35737779-CE28AD8A-27FB-4ED1-A5E5-3164233AF96DQ35809633-687F0F37-529E-4B0A-8C3F-60BBE956D773Q35986087-76C38A19-9FC9-4A5C-967B-866F21C5E8A8Q36138538-38286A20-1DCD-4862-AC16-68266B676CF9Q36682230-D7A0ECDB-644E-4F15-8C29-24EF64D55592Q37354085-829AFF2C-7966-442D-B619-85654FA7242EQ37615017-F330C238-BD94-4F6A-8442-F92BC3E713F7Q37686585-EE413877-1189-4482-A2B9-57876FA1868DQ37695300-BCEF8345-90F1-46D4-AFF6-D55399C62D23Q38020247-FB371056-D5C3-41EA-8421-A78C1E563D66Q38412880-657C6CFC-A8B9-42EB-9DDA-3D14E89A00C3Q38737240-E2EAA54E-9A77-4246-A180-B7F9D3DA06EFQ39180303-44803F1D-47A3-4DD7-BA65-90E7F86838E6Q39526606-C568B6EF-2708-4473-8C30-8641104E7AB2Q43185064-6D9FA64E-AD1F-411E-AF1E-F3A736CF9F27
P2860
EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@en
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@nl
type
label
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@en
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@nl
prefLabel
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@en
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@nl
P2093
P2860
P1476
EB1089 inhibits the parathyroi ...... f human prostate cancer cells.
@en
P2093
Manjit K Saini
Miriam Falzon
Nancy L Weigel
Suimin Qiu
Vandanajay Bhatia
Xiaoli Shen
P2860
P304
P356
10.1158/1535-7163.MCT-09-0064
P577
2009-07-07T00:00:00Z